Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rajala, U.
Right arrow Articles by Keinanen-Kiukaanniemi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajala, U.
Right arrow Articles by Keinanen-Kiukaanniemi, S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes Care, Vol 21, Issue 10 1664-1669, Copyright © 1998 by American Diabetes Association


ARTICLES

Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance

U Rajala, M Laakso, Q Qiao and S Keinanen-Kiukaanniemi
Department of Public Health Science and General Practice, University of Oulu and Oulu University Hospital, Finland.

OBJECTIVE: Recently, an international expert committee published new revised criteria for diagnosing diabetes. According to the new criteria, the 2-h glucose level for diabetes in the oral glucose tolerance test (OGTT) is the same as in the previous World Health Organization criteria, but the cut point for the fasting blood glucose level has been lowered to be equivalent to the 2-h OGTT level. Measurement of the fasting blood glucose level is preferred to the 2-h OGTT glucose level. The ability of the new cut point for fasting blood glucose to discriminate between those at a high and a low risk for retinopathy was tested in a population-based study RESEARCH DESIGN AND METHODS: The population consisted of all the 1,008 subjects (456 men) born in 1935 and living in a Finnish city A screening for type 2 diabetes was carried out in the first phase. All participants who were not on antidiabetic medication were invited for an OGTT in the second phase. A fasting blood glucose value was measured from the diabetic subjects on antidiabetic medication. In addition, measurements of serum cholesterol, HDL cholesterol, and triglycerides were made, and fundus photographs were taken. Altogether, 831 subjects (368 men) (82%) participated and constitute the eligible study population for the present analyses. Fundus photographs were available for 790 subjects (347 men) (95%). RESULTS: There were 28 subjects (3.5%) who had mild retinopathic changes in the fundus photographs. Retinopathic changes were associated with higher fasting blood glucose levels, but not with any of the other background factors. The prevalence of retinopathy was 10.2% (95% CI 4.8-18.5) in subjects with a fasting blood glucose of > or =6.1 mmol/l, while it was 2.6% (1.5-4.0) in those with a lower fasting blood glucose level. In the former group, a majority (seven of nine) of the subjects with retinopathy were previously diagnosed diabetic patients. Some cases of retinopathy were found regardless the level of glycemia, and measurement of the 2-h OGTT glucose levels did not increase information. CONCLUSIONS: The results of this population study give support to the use of fasting blood glucose levels in diagnosing type 2 diabetes. The lower limit of the highest decile of the fasting glucose level was 6.1 mmol/l, and it discriminated subjects at a high risk for retinopathy from those at a low risk. Because of the limited number of subjects with retinopathy in this study, the level of hyperglycemia associated with retinopathy cannot be estimated accurately.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Fam PractHome page
P. Janssen, K. Gorter, R. Stolk, and G. Rutten
Low yield of population-based screening for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study
Fam. Pract., December 1, 2007; 24(6): 555 - 561.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
F. E. Hirai, S. E. Moss, M. D. Knudtson, B. E. K. Klein, and R. Klein
Retinopathy and Survival in a Population without Diabetes: The Beaver Dam Eye Study
Am. J. Epidemiol., September 15, 2007; 166(6): 724 - 730.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. D.M. Stork, T. W. van Haeften, and T. F. Veneman
Diabetes and Driving: Desired data, research methods and their pitfalls, current knowledge, and future research
Diabetes Care, August 1, 2006; 29(8): 1942 - 1949.
[Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
T Y Wong, Q Mohamed, R Klein, and D J Couper
Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes?
Br. J. Ophthalmol., March 1, 2006; 90(3): 301 - 303.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Glumer, D. Vistisen, K. Borch-Johnsen, S. Colagiuri, and on behalf of the DETECT-2 Collaboration
Risk Scores for Type 2 Diabetes Can Be Applied in Some Populations but Not All
Diabetes Care, February 1, 2006; 29(2): 410 - 414.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Prevention or Delay of Type 2 Diabetes
Diabetes Care, January 1, 2004; 27(90001): s47 - 47.
[Full Text] [PDF]


Home page
Diabetes CareHome page
The Prevention or Delay of Type 2 Diabetes
Diabetes Care, January 1, 2003; 26(90001): s62 - 69.
[Full Text] [PDF]


Home page
Diabetes CareHome page
H. A. van Leiden, J. M. Dekker, A. C. Moll, G. Nijpels, R. J. Heine, L. M. Bouter, C. D.A. Stehouwer, and B. C.P. Polak
Blood Pressure, Lipids, and Obesity Are Associated With Retinopathy: The Hoorn Study
Diabetes Care, August 1, 2002; 25(8): 1320 - 1325.
[Abstract] [Full Text] [PDF]


Home page
Clin. DiabetesHome page
The Prevention or Delay of Type 2 Diabetes
Clin. Diabetes, July 1, 2002; 20(3): 109 - 116.
[Full Text] [PDF]


Home page
Diabetes Spectr.Home page
The Prevention or Delay of Type 2 Diabetes
Diabetes Spectr, July 1, 2002; 15(3): 147 - 157.
[Full Text] [PDF]


Home page
Diabetes CareHome page
American Diabetes Association
The Prevention or Delay of Type 2 Diabetes
Diabetes Care, April 1, 2002; 25(4): 742 - 749.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1998 by the American Diabetes Association.